We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Human Micobiome Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

  • Report Code : 591475
  • Industry : Medical Devices
  • Published On : Nov 2020
  • Pages : 107
  • Publisher : 99strategy
  • Format: WMR PPT FormatWMR PDF Format

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
.
The global Human Micobiome market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Human Micobiome are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Human Micobiome market segmented into
Treatment
Urogenital Tract Human Micobiome
Others

Based on the end-use, the global Human Micobiome market classified into
Treatment
Diagnosis

Based on geography, the global Human Micobiome market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC.

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL HUMAN MICOBIOME INDUSTRY
2.1 Summary about Human Micobiome Industry
2.2 Human Micobiome Market Trends
2.2.1 Human Micobiome Production & Consumption Trends
2.2.2 Human Micobiome Demand Structure Trends
2.3 Human Micobiome Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Gastrointestinal Tract Human Micobiome
4.2.2 Urogenital Tract Human Micobiome
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Treatment
4.3.2 Diagnosis
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Gastrointestinal Tract Human Micobiome
5.2.2 Urogenital Tract Human Micobiome
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Treatment
5.3.2 Diagnosis
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Gastrointestinal Tract Human Micobiome
6.2.2 Urogenital Tract Human Micobiome
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Treatment
6.3.2 Diagnosis
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Gastrointestinal Tract Human Micobiome
7.2.2 Urogenital Tract Human Micobiome
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Treatment
7.3.2 Diagnosis
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Gastrointestinal Tract Human Micobiome
8.2.2 Urogenital Tract Human Micobiome
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Treatment
8.3.2 Diagnosis
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Gastrointestinal Tract Human Micobiome
9.2.2 Urogenital Tract Human Micobiome
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Treatment
9.3.2 Diagnosis
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Vedanta
10.1.2 Seres Therapeutics
10.1.3 Second Genome
10.1.4 Rebiotix
10.1.5 ActoGeniX
10.1.6 Enterome BioScience
10.1.7 AvidBiotics
10.1.8 4D Pharma Research Ltd
10.1.9 Enterologics
10.1.10 Metabogen
10.1.11 Metabiomics
10.1.12 Ritter Pharmaceuticals
10.1.13 Osel
10.1.14 Symberix
10.1.15 Miomics
10.1.16 Symbiotix Biotherapies
10.1.17 MicroBiome Therapeutics LLC.
10.2 Human Micobiome Sales Date of Major Players (2017-2020e)
10.2.1 Vedanta
10.2.2 Seres Therapeutics
10.2.3 Second Genome
10.2.4 Rebiotix
10.2.5 ActoGeniX
10.2.6 Enterome BioScience
10.2.7 AvidBiotics
10.2.8 4D Pharma Research Ltd
10.2.9 Enterologics
10.2.10 Metabogen
10.2.11 Metabiomics
10.2.12 Ritter Pharmaceuticals
10.2.13 Osel
10.2.14 Symberix
10.2.15 Miomics
10.2.16 Symbiotix Biotherapies
10.2.17 MicroBiome Therapeutics LLC.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Table
1.Table Human Micobiome Product Type Overview
2.Table Human Micobiome Product Type Market Share List
3.Table Human Micobiome Product Type of Major Players
4.Table Brief Introduction of Vedanta
5.Table Brief Introduction of Seres Therapeutics
6.Table Brief Introduction of Second Genome
7.Table Brief Introduction of Rebiotix
8.Table Brief Introduction of ActoGeniX
9.Table Brief Introduction of Enterome BioScience
10.Table Brief Introduction of AvidBiotics
11.Table Brief Introduction of 4D Pharma Research Ltd
12.Table Brief Introduction of Enterologics
13.Table Brief Introduction of Metabogen
14.Table Brief Introduction of Metabiomics
15.Table Brief Introduction of Ritter Pharmaceuticals
16.Table Brief Introduction of Osel
17.Table Brief Introduction of Symberix
18.Table Brief Introduction of Miomics
19.Table Brief Introduction of Symbiotix Biotherapies
20.Table Brief Introduction of MicroBiome Therapeutics LLC.
21.Table Products & Services of Vedanta
22.Table Products & Services of Seres Therapeutics
23.Table Products & Services of Second Genome
24.Table Products & Services of Rebiotix
25.Table Products & Services of ActoGeniX
26.Table Products & Services of Enterome BioScience
27.Table Products & Services of AvidBiotics
28.Table Products & Services of 4D Pharma Research Ltd
29.Table Products & Services of Enterologics
30.Table Products & Services of Metabogen
31.Table Products & Services of Metabiomics
32.Table Products & Services of Ritter Pharmaceuticals
33.Table Products & Services of Osel
34.Table Products & Services of Symberix
35.Table Products & Services of Miomics
36.Table Products & Services of Symbiotix Biotherapies
37.Table Products & Services of MicroBiome Therapeutics LLC.
38.Table Market Distribution of Major Players
39.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
40.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
41.Table Global Human Micobiome Market Forecast (Million USD) by Region 2021f-2026f
42.Table Global Human Micobiome Market Forecast (Million USD) Share by Region 2021f-2026f
43.Table Global Human Micobiome Market Forecast (Million USD) by Demand 2021f-2026f
44.Table Global Human Micobiome Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
1.Figure Global Human Micobiome Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Human Micobiome Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Human Micobiome Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Human Micobiome Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Human Micobiome Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Human Micobiome Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Human Micobiome Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Gastrointestinal Tract Human Micobiome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Urogenital Tract Human Micobiome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Diagnosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Gastrointestinal Tract Human Micobiome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Urogenital Tract Human Micobiome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Diagnosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Gastrointestinal Tract Human Micobiome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Urogenital Tract Human Micobiome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Diagnosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Gastrointestinal Tract Human Micobiome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Urogenital Tract Human Micobiome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Diagnosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Gastrointestinal Tract Human Micobiome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Urogenital Tract Human Micobiome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Diagnosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Gastrointestinal Tract Human Micobiome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Urogenital Tract Human Micobiome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Diagnosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Human Micobiome Sales Revenue (Million USD) of Vedanta 2017-2020e
66.Figure Human Micobiome Sales Revenue (Million USD) of Seres Therapeutics 2017-2020e
67.Figure Human Micobiome Sales Revenue (Million USD) of Second Genome 2017-2020e
68.Figure Human Micobiome Sales Revenue (Million USD) of Rebiotix 2017-2020e
69.Figure Human Micobiome Sales Revenue (Million USD) of ActoGeniX 2017-2020e
70.Figure Human Micobiome Sales Revenue (Million USD) of Enterome BioScience 2017-2020e
71.Figure Human Micobiome Sales Revenue (Million USD) of AvidBiotics 2017-2020e
72.Figure Human Micobiome Sales Revenue (Million USD) of 4D Pharma Research Ltd 2017-2020e
73.Figure Human Micobiome Sales Revenue (Million USD) of Enterologics 2017-2020e
74.Figure Human Micobiome Sales Revenue (Million USD) of Metabogen 2017-2020e
75.Figure Human Micobiome Sales Revenue (Million USD) of Metabiomics 2017-2020e
76.Figure Human Micobiome Sales Revenue (Million USD) of Ritter Pharmaceuticals 2017-2020e
77.Figure Human Micobiome Sales Revenue (Million USD) of Osel 2017-2020

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
  • Types
  • Applications
  • Technology
  • End-use Industries
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers and restraints
  • Regulatory scenario
  • Industry trend
  • Pestle analysis
  • Porter’s analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Competitive landscape
It helps the businesses in making strategic decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved